SpringWorks

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell SpringWorks and other ETFs, options, and stocks.

About SWTX

Springworks Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the application of a medicine approach to acquiring, developing, and commercializing medicines. Its pipeline includes Nirogacestat, Mirdametinib, Brimarafenib, SW-682, and EGFR Inhibitor.

CEO

Saqib Islam

CEOSaqib Islam

Employees

305

Employees305

Headquarters

Stamford, Connecticut

HeadquartersStamford, Connecticut

Founded

2017

Founded2017

Employees

305

Employees305

SWTX Key Statistics

Market cap

3.43B

Market cap3.43B

Price-Earnings ratio

-9.29

Price-Earnings ratio-9.29

Dividend yield

—

Dividend yield—

Average volume

1.21M

Average volume1.21M

High today

$46.42

High today$46.42

Low today

$44.61

Low today$44.61

Open price

$45.33

Open price$45.33

Volume

607.53K

Volume607.53K

52 Week high

$53.92

52 Week high$53.92

52 Week low

$18.00

52 Week low$18.00

Analyst ratings

100%

of 9 ratings

Buy

100%

Hold

Sell

SpringWorks

Why Robinhood?

Springworks Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the application of a medicine approach to acquiring, developing, and commercializing medicines. Its pipeline includes Nirogacestat, Mirdametinib, Brimarafenib, SW-682, and EGFR Inhibitor. Show more

SWTX Key Statistics

Analyst ratings

100%

Springworks Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the application of a medicine approach to acquiring, developing, and commercializing medicines. Its pipeline includes Nirogacestat, Mirdametinib, Brimarafenib, SW-682, and EGFR Inhibitor.